Mumbai13 hours ago
- copy link
Today is the second day of subscription of Initial Public Offer i.e. IPO of Emcure Pharmaceuticals Limited and Bansal Wire Industries Limited. Emcure Pharmaceuticals Limited’s IPO total was subscribed 1.34 times on the first day. The issue was subscribed 1.46 times in the retail category, 0.07 times in the Qualified Institutional Buyers (QIB) category and 2.78 times in the Non-Institutional Investors (NII) category.
At the same time, the IPO of Bansal Wire Industries Limited was subscribed a total of 1.88 times on the first day. The issue was subscribed 2.65 times in the retail category, 0.01 times in the QIB category and 5.54 times in the NII category. Retail investors can bid for both IPOs till tomorrow i.e. 5th July. Shares of both the companies will be listed in the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) on July 10.
Let us now know about the IPOs of these two companies one by one:-
1. Emcure Pharmaceuticals Ltd
Emcure Pharmaceuticals Limited wants to raise a total of ₹1,952.03 crore through this IPO. For this, the company is issuing 7,936,507 fresh shares worth ₹800 crore. Whereas, the existing investors of the company are selling 11,428,839 shares worth ₹ 1,152.03 crore through Offer for Sale i.e. OFS.
Retail investors can bid for maximum 196 shares
Emcure Pharmaceuticals Limited has fixed the price band of this issue at ₹960-₹1008. Retail investors can bid for a minimum of one lot i.e. 14 shares. If you apply for 1 lot as per the upper price band of IPO of ₹ 1008, then you will have to invest ₹ 14,112.
At the same time, retail investors can apply for maximum 13 lots i.e. 196 shares. For this, investors will have to invest ₹ 197,568 as per the upper price band.
Emcure Pharmaceuticals’ premium in gray market 32.74%
Before listing, the company’s shares have reached a premium of 32.74% i.e. ₹ 330 per share in the gray market. In such a situation, according to the upper price band of ₹ 1008, its listing can be at ₹ 1338. Although this can only be an estimate, the listing price of a share is different from the gray market price.
Emcure Pharmaceuticals was established in 1981
Emcure Pharmaceuticals is an Indian pharmaceutical company, which was established in 1981. Along with manufacturing medicines and marketing them at the global level, the company also does research.
Emcure Pharmaceuticals has 13 manufacturing facilities in India. These facilities can produce a variety of pharmaceutical and biopharmaceutical products, including tablets, liquid essences, and injections.
2. Bansal Wire Industries Limited
Bansal Wire Industries Limited wants to raise a total of ₹745 crore through this IPO. For this, the company is issuing 29,101,562 issues worth ₹745 crore. The existing investors of the company are not selling even a single share through Offer for Sale.
Retail investors can bid for maximum 754 shares
Bansal Wire Industries Limited has fixed the price band of this issue at ₹243-₹256. Retail investors can bid for a minimum of one lot i.e. 58 shares. If you apply for 1 lot as per the upper price band of IPO at ₹256, then you will have to invest ₹14,848.
At the same time, retail investors can apply for maximum 13 lots i.e. 754 shares. For this, investors will have to invest ₹ 193,024 as per the upper price band.
Bansal Wire Industries premium in gray market 23.44%
Before listing, the company’s shares have reached a premium of 23.44% i.e. ₹ 60 per share in the gray market. In such a situation, according to the upper price band of ₹ 256, its listing can be at ₹ 316. Although this can only be estimated, the listing price of a share is different from the gray market price.
Bansal Wire Industries was established in 1985
Bansal Wire Industries Limited is a stainless steel wire manufacturing company, established in December 1985. The company manufactures more than 3,000 types of steel wire products, ranging in size from very thin to very thick. Along with selling its products in the country, the company also exports its products to more than 50 countries.
35% share reserved for retail investors in both IPOs
In both IPOs, 50% of the issue has been reserved for Qualified Institutional Buyers (QIB). Apart from this, 35% share is reserved for retail investors and the remaining 15% share is reserved for non-institutional investors (NII).
What is IPO?
When a company issues its shares to the general public for the first time, it is called Initial Public Offering i.e. IPO. The company needs money to expand its business. In such a situation, instead of taking loan from the market, the company raises money by selling some shares to the public or issuing new shares. For this the company brings IPO.
